BSTZ NYSE Week ended 07 Aug 2026

Weekly Investor Report

BlackRock Science and Technology Trust II · Financial Services · Asset Management

Open interactive chart View report data
Latest close 30.08 USD
5.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 17.7% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned 5.8%, after a 2.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal.

Setup score 67 out of 100
Latest Close 30.08 USD 7 Aug 2026
1W Return 5.8% latest completed week
4W Return 2.6% short-term follow-through
12W Return 8.5% quarterly tape
Trend Breadth 98.1% 51 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 19-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 60.36% based on similar historical setup states.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 5.8% Latest completed week; four-week move 2.6%. Indicator stack 99/30 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 60.36% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 52/100 27 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 17.7% above the Trend Line and sits at 87.4% of its 52-week range. The latest completed week returned 5.8%, after a 2.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8512-week average 0.89

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.85Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.6% over four weeks, 8.5% over 12 weeks, and 52.8% over one year. The current trend has remained active for 19 consecutive weeks.

Performance by holding period

1W5.8%
4W2.6%
12W8.5%
26W37.7%
52W52.8%
Active trend streak19 weeks
Active weeks in one year51
Trend breadth98.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.43Latest activity-pressure read.
Pressure change-149.4%Four-week change in activity pressure.
Leadership14.76Latest relative-leadership reading.
RS change-10.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 94% Model confidence 75%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength88/100Blend of value, momentum, and quality. Underlying universe rank 13; rank 1 is best.
Value87/100Relative valuation strength. Underlying universe rank 14; rank 1 is best.
Quality29/100Profitability and accounting quality. Underlying universe rank 72; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth67/100Revenue and earnings growth. Underlying universe rank 34; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
3.5x
Price divided by trailing earnings.
Price / sales
5.7x
Market value relative to trailing revenue.
EV / EBITDA
3.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-6.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
79.0%
Gross profit retained from each unit of revenue.
Operating margin
153.0%
Operating profit retained from revenue.
Free-cash-flow margin
-38.5%
Free cash flow generated from revenue.
Return on invested capital
23.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
227.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
8.0%
Cash dividends relative to market value.
Buyback yield
35.0%
Net share repurchases relative to market value.
Shareholder yield
43.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 27 relevant articles.

5 positive · 20 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.1%Distance below the 52-week high.
13-week volatility4.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher20 of 266 weeks finished lower.
Best week+7.2%Week of 17 Apr.
Worst week-8.5%Week of 26 Jun.
Latest week+5.8%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains12
Flat weeks0
Modest losses2
Sharp losses4
Recent vol4.4%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape70/100

Trend, activity pressure, participation, and risk combine to a 70/100 tape read.

 Indicator analysis79/100

Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 12/12.

Activity pressure 0.85; 3 reversal markers Next-Week ExpectancyPositive 60.36%

Next-week expectancy is positive with a 60.36% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors72/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 2; Small Cap Core rank 12 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 27 relevant articles.

BlackRock Science & Tech Term Trust (BSTZ) plans CCO return in 2026 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202630.08 USD5.8%25.57 USD18.04 USD-0.4314.76957.9KOn
31 Jul 202628.43 USD-0.9%25.29 USD17.93 USD-0.2712.761.1MOn
24 Jul 202628.69 USD4.1%25.09 USD17.83 USD0.1215.48796.8KOn
17 Jul 202627.57 USD-5.9%24.86 USD17.73 USD0.5110.851.1MOn
10 Jul 202629.31 USD0.3%24.67 USD17.64 USD0.8816.41997.7KOn
3 Jul 202629.23 USD3.3%24.40 USD17.54 USD1.0818.291.9MOn
26 Jun 202628.28 USD-8.5%24.13 USD17.44 USD1.1317.581.8MOn
19 Jun 202630.92 USD1.7%23.88 USD17.34 USD1.2126.09695.3KOn
12 Jun 202630.41 USD5.2%23.51 USD17.22 USD1.2626.05716.2KOn
5 Jun 202628.90 USD-4.4%23.17 USD17.11 USD1.3621.291.3MOn
29 May 202630.24 USD5.9%22.90 USD17.01 USD1.4324.47939.0KOn
22 May 202628.55 USD3.0%22.61 USD16.90 USD1.5119.971.0MOn
15 May 202627.73 USD0.2%22.33 USD16.80 USD1.5518.141.2MOn
8 May 202627.67 USD3.7%22.07 USD16.69 USD1.3918.731.0MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context